No studies are currently available on the anti-leukemic properties of CCL20 in AML, but it can be speculated that CCL20 secreted by AML cells might promote the migration of cytotoxic lymphocytes, which have anti-tumor effects [105]. The gene discussed is CCL20; the disease is neoplasm.